Revium Rx (RVRC) Retained Earnings (2024 - 2025)
Revium Rx recorded quarterly Retained Earnings of -$25.0 million in Q4 2025, down 116.82% quarter-over-quarter from -$11.5 million in Q4 2024, and down 116.82% year-over-year from $148.4 million in Q4 2024.
Revium Rx's Retained Earnings history runs 2 years deep, the most recent figure standing at -$25.0 million for Q4 2025.
- In Q4 2025, Retained Earnings fell 116.82% year-over-year to -$25.0 million; the TTM figure through Dec 2025 stood at -$25.0 million (down 116.82% YoY), while the FY2025 annual figure was -$25.0 million, down 116.82% from the prior year.
- Retained Earnings came in at -$25.0 million for Q4 2025 at Revium Rx, down from -$11.5 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$11.5 million in Q4 2024 to a low of -$25.0 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 4.36 Bn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 14.14 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 177.20 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | -348,000.00 |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 28,000.00 |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 846,000.00 |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -1.52 Bn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | -153.25 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | -10.64 Mn |
| 10 | Revium Rx | - | - | - | -24.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -24.96 Mn |
| Dec 31, 2024 | -11.51 Mn |